Histopathology of vascular anomalies

Clinics in Plastic Surgery

Volumn 38, Issue 1, 2011, Pages 31-44

  Gupta, Anita ^a   Kozakewich, Harry ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Hemangioma; Immunohistochemical stain; Pyogenic granuloma; Vascular malformation; Vascular tumor

Indexed keywords

GLUCOSE TRANSPORTER 1; KI 67 ANTIGEN; PODOPLANIN; SMOOTH MUSCLE ACTIN; VASCULOTROPIN RECEPTOR 3;

ARTERIOVENOUS MALFORMATION; CAPILLARY MALFORMATION; CONGENITAL BLOOD VESSEL MALFORMATION; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFANTILE HEMANGIOMA; KAPOSIFORM HEMANGIOENDOTHELIOMA; LYMPHATIC MALFORMATION; NEVUS FLAMMEUS; NONINVOLUTING CONGENITAL HEMANGIOMA; PTEN HAMARTOMA OF SOFT TISSUE; PYOGENIC GRANULOMA; RAPIDLY INVOLUTING CONGENITAL HEMANGIOMA; REVIEW; TUFTED ANGIOMA; VEIN MALFORMATION;

BIOLOGICAL MARKERS; HEMANGIOMA; HUMANS; VASCULAR MALFORMATIONS;

EID: 78649284224     PISSN: 00941298     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cps.2010.08.007     Document Type: Review

References (66)

1. Mulliken J.B., Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982, 69:412-422.
2. Enjolras O., Mulliken J.B. Vascular tumors and vascular malformations (new issues). Adv Dermatol 1998, 13:375.
3. North P.E., Waner M., Mizeracki A., et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000, 3:11-22.
4. North P.E., Waner M., James C.A., et al. Congenital non-progressive hemangioma: a distinct clinicopathologic entity unlike infantile hemangioma. Arch Dermatol 2001, 137:1607-1620.
5. Enjolras O., Mulliken J.B., Boon L.M., et al. Noninvoluting congenital hemangioma; a rare cutaneous vascular anomaly. Plast Reconstr Surg 2001, 107:1647-1654.
6. Takahashi K., Mulliken J.B., Kozakewich H.P., et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994, 93:2357-2364.
7. Costa da Cunha Castro E Galambos C. Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations: a proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations. Pediatr Dev Pathol 2009, 12:187-194.
8. Debelenko L.V., Perez-Atayde A.R., Mulliken J.B., et al. D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Mod Pathol 2005, 18:1454-1460.
9. Folpe A.L., Veikkola T., Valtola R., et al. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform hemangioendothelioma and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod Pathol 2000, 13:180-185.
10. Galambos C., Nodit L. Identification of lymphatic endothelium in pediatric vascular tumors and malformations. Pediatr Dev Pathol 2005, 8:181-189.
11. Glowacki J., Mulliken J.B. Mast cells in hemangiomas and vascular malformations. Pediatrics 1982, 70:48-51.
12. North P.E., Waner M., Buckmiller L., et al. Vascular tumors of infancy and childhood: beyond capillary hemangioma. Cardiovasc Pathol 2006, 15:303-317.
13. Boon L.M., Fishman S.J., Lund D.P., et al. Congenital fibrosarcoma masquerading as a congenital hemangioma: report of two cases. J Pediatr Surg 1995, 30:1378-1381.
14. Boon L.M., Enjolras O., Mulliken J.B. Congenital hemangioma: evidence of accelerated involution. J Pediatr 1996, 128:329-335.
15. Mulliken J.B., Bischoff J., Kozakewich H.P.W. Multifocal rapidly involuting congenital hemangioma. A link to chorangioma. Am J Med Genet A 2007, 3A:3038-3046.
16. Berenguer B., Mulliken J.B., Enjolras O., et al. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol 2003, 6:495-510.
17. Wilson-Jones E., Orkin M. Tufted angioma (angioblastoma). A benign progressive angioma, not to be confused with Kaposi's sarcoma or low grade angiosarcoma. J Am Acad Dermatol 1989, 28:214-225.
18. Padilla R.S., Orkin M., Rosai J. Acquired "tufted" angioma (progressive capillary hemangioma). A distinctive entity related to lobular capillary hemangioma. Am J Dermatopathol 1987, 9:292-300.
19. Okada E., Tamura A., Ishikawa O., et al. Tufted angiomas (angioblastomas): case report and review of 41 cases in the Japanese literature. Clin Exp Dermatol 2000, 25:627-630.
20. Chu C.Y., Hsaio C.H., Chiu H.C. Transformation between kaposiform hemangioendothelioma and tufted angioma. Dermatology 2003, 206:334-337.
21. Tsang W.Y., Chan J.K.C. Kaposi-like infantile hemangioendothelioma: a distinctive vascular neoplasm of the retroperitoneum. Am J Surg Pathol 1991, 15. 982-9.
22. Zukerberg L.R., Nickoloff B.J., Weiss S.W. Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 1993, 17:321-328.
23. Sarkar M., Mulliken J.B., Kozakewich H.P., et al. Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with Kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 1997, 100:1377-1386.
24. Enjolras O., Wassef M., Mazoyer E., et al. Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J Pediatr 1997, 130:631-640.
25. Enjolras O., Mulliken J.B., Wassef M., et al. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 2000, 42:225-235.
26. Lyons L.L., North P.E., Mac-Maoune Lai F., et al. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 2004, 28:559-568.
27. Gruman A., Liang M.G., Mulliken J.B., et al. Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. J Am Acad Dermatol 2005, 52:616-622.
28. Bruder E., Perez-Atayde A., Jundt G., et al. Vascular lesions of bone in children, adolescents, and young adults. Virchows Arch 2009, 454:161-179.
29. Cheuk W., Wong K.O., Wong C.S., et al. Immunostaining for human herpesvirus 8 latent nuclear antigen-1 helps distinguish Kaposi sarcoma from mimickers. Am J Clin Pathol 2004, 121:335-342.
30. Patrice S.J., Wiss K., Mulliken J.B. Pyogenic granuloma (lobular capillary hemangioma): a clinicopathologic study of 178 cases. Pediatr Dermatol 1991, 8:267-276.
31. Saravana G.H. Oral pyogenic granuloma: a review of 137 cases. Br J Oral Maxillofac Surg 2009, 47:318-319.
32. Jafarzadeh H., Sanatkahani M., Mohtasham N. Oral pyogenic granuloma: a review. J Oral Sci 2006, 48:167-175.
33. Pereira C.M., de Almeida O.P., Correa M.E., et al. Oral involvement in chronic graft versus host disease: a prospective study of 19 Brazilian patients. Gen Dent 2007, 55:48-51.
34. Browning J.C., Eldin K.W., Kozakewich H.P., et al. Congenital disseminated pyogenic granuloma. Pediatr Dermatol 2009, 26:323-327.
35. Walter D.L., Parker N.P., Kim O.S., et al. Lobular capillary hemangioma of the neonatal larynx. Arch Otolaryngol Head Neck Surg 2008, 134:272-277.
36. Ogunleye A.O., Nwaaorgu O.G. Pyogenic granuloma, a cause of a congenital nasal mass: case report. Ann Trop Paediatr 2000, 20:137-139.
37. Happle R. What is a capillary malformation?. J Am Acad Dermatol 2008, 59:1077-1079.
38. Finley J.L., Noe J.M., Arndt K., et al. Port wine stains: morphologic variations and developmental lesions. Arch Dermatol 1984, 120:1453-1455.
39. Maari C., Frieden I.J. Klippel-Trénaunay syndrome: the importance of "geographic stains" in identifying lymphatic disease and risk of complications. J Am Acad Dermatol 1994, 31:391-396.
40. Barsky S.H., Rosen S., Geer D.E., et al. The nature and evolution of port wine stains: a computer-assisted study. J Invest Dermatol 1980, 74:154-157.
41. Greene A.K., Tabler S.F., Ball K.L., et al. Sturge-Weber syndrome: soft-tissue and skeletal overgrowth. J Craniofac Surg 2009, 20(Suppl 1):617-621.
42. Mills C.M., Lanigan S.W., Hughes J., et al. Demographic study of port wine stain patients attending a laser clinic: family history, prevalence of nevus anaemicus with results of prior treatment. Clin Exp Dermatol 1997, 22:166-168.
43. Sanchez-Carpintero I., Mihm M.C., Mizeracki A., et al. Epithelial and mesenchymal hamartomatous changes in a mature port-wine stain: morphologic evidence for a multiple germ layer field defect. J Am Acad Dermatol 2004, 50:608-612.
44. Hein K.D., Mulliken J.B., Kozakewich H.P.W., et al. Venous malformations of skeletal muscle. Plast Reconstr Surg 2002, 110:1625-1635.
45. Mulliken J.B., Fishman S.J., Burrows P.E. Vascular anomalies. Curr Probl Surg 2000, 37:517-584.
46. Boon L.M., Mulliken J.B., Enjolras O., et al. Glomuvenous malformation (glomangioma) and venous malformation; distinct clinicopathologic and genetic entities. Arch Dermatol 2004, 140:971-976.
47. Folpe A.L., Fanburg-Smith J.C., Miettinen M., et al. Atypical and malignant glomus tumors: analysis of 52 cases, with a proposal for the reclassification of glomus tumors. Am J Surg Pathol 2001, 25:1-12.
48. Enzinger and Weiss's soft tissue tumors 2008, Mosby, Elsevier, Philadelphia. S.W. Weiss, J.R. Goldblum (Eds.).
49. Del Curling O., Kelly D.L., Elster A.D., et al. An analysis of the natural history of cavernous angiomas. J Neurosurg 1991, 75:702-708.
50. Sirventi A., Enjolras O., Wassef M., et al. Frequency and genotypes of cutaneous vascular malformations in a consecutive series of 417 patients with familial cerebral cavernous malformations. J Eur Acad Dermatol Venereol 2009, 9:1066-1072.
51. Vikkula M., Boon L.M., Enjolras O., et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 1996, 87:1181-1190.
52. Wouters V., Limaye N., Uebelhoer A., et al. Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur J Hum Genet 2010, 18:414-420.
53. Whimster I.W. The pathology of lymphangioma circumscriptum. Br J Dermatol 1976, 94:473-486.
54. Kinmonth J.B. The lymphatics 1982, Edward Arnold, London.
55. Fishman S.J., Burrows P.E., Hendren W.H. Life-threatening anomalies of the thoracic duct: anatomic delineation dictates management. J Pediatr Surg 2001, 36:1269-1272.
56. Meijer-Jorna L.B., van der Loos C.M., de Boer O.J., et al. Microvascular proliferation in congenital vascular malformations of skin and soft tissue. J Clin Pathol 2007, 60:798-803.
57. Garzon M.C., Huang J.T., Enjolras I., et al. Vascular malformations. Part 1. J Am Acad Dermatol 2007, 56:353-370.
58. Khalid S.K., Garcia-Tsao G. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia. Semin Liver Dis 2008, 28:247-258.
59. Revencu N., Boon L.M., Mulliken J.B., et al. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations. Hum Mutat 2008, 29:959-965.
60. Eerola I., Boon L.M., Mulliken J.B., et al. Capillary malformation-arteriovenous malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 2003, 73:1204-1209.
61. Fargnoli M.C., Orlow S.J., Semel-Concepcion J., et al. Clinicopathologic findings in the Bannayan-Riley-Ruvalcaba syndrome. Arch Dermatol 1996, 132:1214-1218.
62. Tan W.H., Baris H.N., Burrows P.E., et al. The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and treatment. J Med Genet 2007, 44:594-602.
63. Zhou X.P., Marsh D.J., Hampel H., et al. Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis. Hum Mol Genet 2000, 22:765-768.
64. Howard E.L., Tennant L.B., Upton J., et al. PTEN-associated vascular anomaly [abstract]. Mod Pathol 2005, 18:309.
65. Leu H.J. Zur Morphologie der arteriovenosen Anastomosen bei kongenitalen Angiodysplasien [in German]. Morphol Med 1982, 2:99.
66. Mulliken J.B., Dethlefson S.M. A preliminary morphologic study of an arteriovenous malformation and adjacent vasculature. Periodica angiologica 1989, 16-50. Einhorn-Presse Verlag, Hamburg (Germany). S.T. Belov, D.A. Loose, J. Weber (Eds.).